A suspenseful game of 'hide and seek' between virus and host

Nature Immunology

Volumn 8, Issue 4, 2007, Pages 325-327

  Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; GAMMA INTERFERON; GLYCOPROTEIN; GLYCOPROTEIN 1; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS RNA;

ARTERITIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS; DENDRITIC CELL; EPSTEIN BARR VIRUS; GLOMERULONEPHRITIS; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INNATE IMMUNITY; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL RESEARCH; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; RETROVIRUS; RNA VIRUS; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; DYSTROGLYCANS; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 34248574356     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni0407-325     Document Type: Article

References (33)

1. Traub, E. Epidemiology of lymphocytic choriomeningitis in a mouse stock observed for four years. J. Exp. Med. 69, 801-817 (1939).
2. Burnet, F.M. & Fenner, F. The Production of Antibodies (ed. Burnet, F.M.) 1-142 (MacMillan, New York, 1949).
3. Oldstone, M.B.A. & Dixon, F.J. Lymphocytic choriomeningitis: Production of anti-LCM antibody by 'tolerant' LCM-infected mice. Science 158, 1193-1194 (1967).
4. Oldstone, M.B.A., Aoki, T. & Dixon, F.J. The antibody response of mice to murine leukemia virus in spontaneous infection. Absence of classical immunologic tolerance, Proc. Natl. Acad. Sci. USA 69, 134-138 (1972).
5. Zinkernagel, R.M. Lymphocytic choriomeningitis virus and immunology. Curr. Top. Microbiol. Immunol. 263, 1-6 (2002).
6. Oldstone, M.B.A., Habel, K. & Dixon, F.J. The pathogenesis of cellular injury associated with persistent LCM viral infection. Fed. Proc. 28, 429-432 (1969).
7. Lundstedt, C. Interaction between antigenically different cells: virus-induced cytotoxicity by immune lymphoid cells in vitro. Acta Pathol. Microbiol. Scand. 75, 139-152 (1969).
8. Cole, G.A., Nathanson, N. & Prendergast, R.A. Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature 238, 335-337 (1972).
9. Zinkernagel, R.M. & Doherty, P.C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248, 701-702 (1974).
10. Ahmed, R. & Gray, D. Immunological memory and protective immunity: Understanding their relation. Science 272, 54-60 (1996).
11. + T-cell memory. Nat. Med. 7, 913-919 (2001).
12. Oldstone, M.B.A., Blount, P., Southern, P.J. & Lampert, P.W. Cytoimmunotherapy for persistent virus infection: Unique clearance pattern from the central nervous system. Nature 321, 239-243 (1986).
13. Volkert, M. & Larsen, J.H. Studies on immunological tolerance to LCM virus. 6. Immunity conferred on tolerant mice by immune sera and by grafts of homologous lymphoid cells. Acta Pathol. Microbiol. Scand. 63, 172-180 (1965).
14. Berger, D.P., Homann, D. & Oldstone, M.B.A. Defining parameters for successful immunocytotherapy of persistent viral infection. Virology 266, 257-263 (2000).
15. Oldstone, M.B.A. Cytotoxic T-lymphocytes in human viral and malaria infections. Curr. Topics Microbiol. Immunol. 189, 1-186 (1994).
16. Ahmed, R., Salmi, A., Butler, L.D., Chiller, J.M. & Oldstone, M.B.A. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160 521-540 (1984).
17. Ahmed, R. & Oldstone, M.B.A. Organ-specific selection of viral variants during chronic infection. J. Exp. Med. 167, 1719-1724 (1988).
18. Salvato, M., Shimomaye, E., Southern, P. & Oldstone, M.B.A. Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-). Virology 164, 517-522 (1988).
19. Salvato, M., Borrow, P., Shimomaye, E. & Oldstone, M.B.A. Molecular basis of viral persistence: A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J. Virol. 65, 1863-1869 (1991).
20. Sevilla, N. et al. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J. Exp. Med. 192, 1249-1260 (2000).
21. Dockter, J., Evans, C.F., Tishon, A. & Oldstone, M.B.A. Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo. J. Virol. 70 1799-1803 (1996).
22. Cao, W. et al. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282, 2079-2081 (1998).
23. Kunz, S., Sevilla, N., McGavern, D.B., Campbell, K.P. & Oldstone, M.B.A. Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan. J. Cell Biol. 155, 301-310 (2001).
24. Sevilla, N., McGavern, D.B., Teng, C., Kunz, S. & Oldstone, M.B.A. Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J. Clin. Invest. 113 737-745 (2004).
25. Moskophidis, D., Lechner, F, Pircher, H. & Zinkernagel, R.M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362, 758-761 (1993).
26. Zajac, A.J. et al. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188 2205-2213 (1998).
27. Brooks, D.G., McGavern, D.B. & Oldstone, M.B.A. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J. Clin. Invest. 116, 1675-1685 (2006).
28. Brooks, D.G. et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12, 1301-1309 (2006).
29. Barber, D.L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687 (2006).
30. Day, C.L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350-354 (2006).
31. + T cells leads to reversible immune dysfunction. Nat. Med. 12, 1198-1201 (2006).
32. + T cell survival in HIV infection. J. Exp. Med. 203, 2281-2292 (2006).
33. Ejrnaes, M. et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203, 2461-2472 (2006).